Hubungan Helicobacter Pylori Cytotoxin-Associated Gene A (CagA) Positif Dan Negatif Dengan Derajat Keparahan Gastritis Berdasarkan Histopatologi
DAFTAR PUSTAKA
1. El-Zimaity HMT. Recent advances in the histopathology of gastritis. Current
Diagnostic Pathology. 2007;13:340-8.
2. Djojoningrat D. Dispepsia Fungsional. Dalam: Sudoyo AW, editor. Buku ajar
Ilmu Penyakit Dalam. Jilid I edisi IV. Jakarta: BP FKUI; 2006: 354-6.
3. Rugge M, Genta RM. Staging and grading of chronic gastritis. Human
pathology. 2005;36:228-33.
4. Hirlan, Gastritis dalam Buku Ajar Ilmu Penyakit Dalam Edisi 5, Internal
Publishing : 2009 ; 509-512
5. Pratomo BW. Gastritis dan gastropati dalam buku ajar gastroenterologi. Edisi
I. Internal publishing. 2011:307-311.
6. Mayo clinic. Gastritis.2014 [diunduh 20 Maret 2015]. Tersedia dari :
http://www.mayoclinic.org
7. Rugge M, Pennelli G, Pilozzi E, Fassan M, Ingravallo G, Russo VM, et al.
Gastritis: the histology report. Digestive and Liver Disease. 2011; 43S:373–
84.
8. Adibi P. Gastritis. [Diunduh 19 Mei 2015]. Tersedia dari: http://med.mui.ac.ir
9. Szoke D. Genetic factors related to the histological and macroscopic lesions of
the stomach. [disertasi]. Budapest: Semmelweis University; 2009: 61-7.
10. Toljamo K. Gastric erosions – clinical significance and pathology. A longterm follow-up study. University of Oulu, Finland:Acta Univ Oul; 2012:80-1.
11. Zakaria Z. The role of interleukin-10 in Helicobacter pylori infection. Master
[Tesis]. Nottingham,UK: University of Nottingham; 2010: 55.
12. Fox JG, Megraud F. Helicobacter. In: Murray PR, editor. Manual of clinical
microbiology. 9th ed. Pensylvania: Elsevier Mosby; 2007 : 947-62.
13. Cesar ACG, Cury PM, Payao SLM. Comparison of histological and molecular
diagnosis of Helicobacter pylori in benign lesions and gastric adenocarcinoma.
Braz J Microbiol. 2005;36(1):261-6.
54
Universitas Sumatera Utara
14. Banerjee A, Mukhopadhyay AK, Paul S, Bhattacharyya A and Swarnakar S.
Unveiling the Intricacies of Helicobacter pylori-induced Gastric Inflammation:
T Helper cells and Matrix Metalloproteinases at a Crossroad. In: Mozsik G,
editor. Current Topics in Gastritis. Croatia: InTech Publishers; 2013: Chapter
7.
15. Hindawi Publishing Corporation BioMed Research International Volume
2014, Article ID 142980, 7 pages [diunduh 20 Februari 2016] .Tersedia dari:
http://dx.doi.org/10.1155/2014/142980
16. Rehnberg-Laiho L, Rautelin H, Koskela P, Sarna S, Pukkala E, Aromaa A, et
al. Decreasing prevalence of helicobacter antibodies in Finland, with reference
to the decreasing incidence of gastric cancer. Epidemiol Infect. 2001;126:4237.
17. Matsukura N, Yamada S, Kato S, Tomtitchong P, Tajiri T, Miki M, et al.
Genetic differences in interleukin-1 betapolymorphisms among four Asian
populations: an analysis of the Asian paradox between H. pylori infection and
gastric cancer incidence. J Exp Clin Cancer Res. 2003; 22: 55-47.
18. Adam B, et al. Cellular immune activation and clinical manifestation of
funcional dyspepsia. Z Gastroenterol 2008;26-46.
19. Elseweidy MM. Helicobacter pylori ifection and its relevant to chronic
gastritis. INTECH.2013.http://dx.doi.org/105772/46056
20. Conteduca vincenza, domenico sansonno, gianfranco lauletta, sabino russi,
giuseppe ingravallo and franco dammacco. H. pylori infection and gastric
cancer: State of the art. international journal of oncology. 2013.42: 5-18.
21. D W, Chey, C B, Wong. American college of gastroenterology guidline on the
management of H.pylori infetion. Am J Gastroenterol 2007;102:1808-1825
22. Lew E. Peptic ulcer disease. In: Greenberger NJ, editor. Current Diagnosis and
Treatment Gastroenterology, Hepatology, and Endoscopy. New York:
McGraw Hill; 2009:175-83.
23. Silva MIG, de Sousa FCF. Gastric ulcer etiology. In: Chai J, editor. Peptic
Ulcer Disease. Shanghai: Intech; 2011:p.3-28.
55
Universitas Sumatera Utara
24. Fornai M, Antonioli L, Colucci R, Tuccori M, Blandizzi C. Pathophysiology
of gastric ulcer development and healing: molecular mechanism and novel
therapeutic options. In: Chai J, editor. Peptic Ulcer Disease. Shanghai: Intech;
2011: 113-42.
25. Jones MK, Tomikawa M, Mohajer B, Tarnawski AS. Gastrointestinal mucosal
regeneration: role of growth factors. Frontiers in Bioscience. 1999b;4:303-9.
26. Brzozowski T, Konturek PC, Konturek SJ, Brzozowska I, Pawlik T. Role of
prostaglandins in gastroprotection and gastric adaptation. Journal of
physiology and pharmacology. 2005; 56:33-55.
27. Tarnawski AS, Chai J, Jones MK. Esophageal and Gastrointestinal
Microcirculation: Essential for Mucosal Protection, a Target for Injury, and a
Critical Component of Injury and Ulcer Healing. In: Ishii H, Suematsu M,
Tanishita K, editor. Organ microcirculation: a gateway to diagnostic and
therapeutic intervention. Tokyo: Springer; 2005:49-61.
28. Mueller A, Merrel DS, Grimm J, Falkow S. Profiling of microdissected gastric
epithelial cells reveals a cell-type specific response to Helicobacter pylori
infection. Gastroenterology. 2004;127:1446–62.
29. Markus S, Ruggiero P, Rappuoli R, Bagnoli F et al. Helicobacter pylori CagA:
from pathogenic mechanisms to its use as an anti-cancer vaccine. Frontier in
immunology. doi: 10.3389/fimmu.2013.00328
30. Akopyants NS, Clifton SW, Kersulyte D et al. Analyses of the cag
pathogenicity island of Helicobacter pylori. Mol Microbiol 1998; 28: 37–53
31. Kuipers EJ, Perez-Perez GI, Meuwissen SG, Blaser MJ. Helicobacter pylori
and atrophic gastritis: importance of the cagA status. J Natl Cancer Inst 1995;
87: 1777–80.
32. Crabtree JE, Taylor JD, Wyatt JI et al. Mucosal IgA recognition of
Helicobacter pylori 120 kDa protein, peptic ulceration, and gastric pathology.
Lancet 1991; 338: 332–5.
33. Blaser MJ, Perez-Perez GI, Kleanthous H et al. Infection with Helicobacter
pylori strains possessing cagA is associated with an increased risk of
developing adenocarcinoma of the stomach. Cancer Res 1995; 55: 2111–15.
56
Universitas Sumatera Utara
34. Parsonnet J, Friedman GD, Orentreich N, Vogelman H. Risk for gastric cancer
in people with CagA positive or CagA negative Helicobacter pylori infection.
Gut 1997; 40: 297–301.
35. Rugge M, Busatto G, Cassaro M et al. Patients younger than 40 years with
gastric carcinoma – Helicobacter pylori genotype and associated gastritis
phenotype. Cancer 1999; 85: 2506–11.
36. Shimoyama T, Fukuda S, Tanaka M, Mikami T, Munakata A, Crabtree JE.
CagA seropositivity associated with development of gastric cancer in a
Japanese population. J Clin Pathol 1998; 51: 225–8.
37. Nomura M, Lee J, Stemmermann GN, Nomura RY, Perez-Perez GI, Blaser
MJ. Helicobacter pylori CagA seropositivity and gastric carcinoma risk in a
Japanese American population. J Infect Dis 2002; 186: 1138–44.
38. Kikuchi S, Crabtree JE, Forman D, Kurosawa M. Association between
infections with CagA-positive or -negative strains of Helicobacter pylori and
risk for gastric cancer in young adults. Am J Gastroenterol 1999; 94: 3455–9.
39. Segal ED, Cha J, Lo J, Falkow S, Tompkins LS. Altered states: Involvement
of phosphorylated CagA in the induction of host cellular growth changes by
Helicobacter pylori. Proc Natl Acad Sci USA 1999; 96: 14 559–64.
40. Asahi M, Azuma T, Ito S et al. Helicobacter pylori CagA protein can be
tyrosine phosphorylated in gastric epithelial cells. J Exp Med 2000; 191: 593–
602.
41. Stein M, Rappuoli R, Covacci A. Tyrosine phosphorylation of the
Helicobacter pylori CagA antigen after cag-driven host cell translocation.
Proc Natl Acad Sci USA 2000; 97: 1263–8.
42. Odenbreit S, Puls J, Sedlmaier B, Gerland E, Fischer W, Haas R.Translocation
of Helicobacter pylori CagA into gastric epithelial cells by type IV secretion.
Science 2000; 287: 1497–500.
43. Backert S, Ziska E, Brinkmann V et al. Translocation of the Helicobacter
pylori CagA protein in gastric epithelial cells by a type IV secretion apparatus.
Cell Microbiol 2000; 2: 155–64.
57
Universitas Sumatera Utara
44. Selbach M, Moese S, Hauck CR, Meyer TF, Backert S. Src is the kinase of the
Helicobacter pylori CagA protein in vitro and in vivo. J Biol Chem 2002; 277:
677-758.
45. Stein M, Bagnoli F, Halenbeck R, Rappuoli R, Fantl WJ, Covacci A. cSrc/Lyn kinases activate Helicobacter pylori CagA through tyrosine
phosphorylation of the EPIYA motifs. Mol Microbiol 2002; 43: 971–80
46. orrea P, Haenszel W, Cuello C, Tannenbaum S, Archer M. A model for gastric
cancer epidemiology. Lancet 1975; 2: 58–60.
47. Yamazaki S, Yamakawa A, Ito Y et al. The CagA protein of Helicobacter
pylori is translocated into epithelial cells and binds to SHP- 2 in human gastric
mucosa. J Infect Dis 2003; 187: 334–7
48. R. Schindler, Gastritis,William Heinmann, London, UK, 1947.
49. Marshall BJ, Warren JR, “Unidentified curved bacilli in the stomach of
patients with gastritis and peptic ulceration,”The Lancet, vol. 1, no. 8390, pp.
1311–1315, 1984.
50. Jacobson BC, Crawford JM, Farraye FM, “GI tract endoscopic and tissue
processing techniques and normal histology in surgical pathology of the GI
tract,” in Liver, Biliary Tract and Pancreas, R. D. Odze and J. R. Goldblum,
Eds., Elsevier,2009.
51. Carneiro F, Fonseca E, Simoes S, “Epithelialdegeneration induced by
Helicobacter pylori,” Human Pathology, vol. 23, no. 11,1992, p. 1314–1315.
52. Leung KM, Hui Pk, Chan W, Thomas T, “Helicobacter pylori-related gastritis
and gastric ulcer: a continuum of progressive epithelial degeneration,”
American Journal of Clinical Pathology, vol. 98, no. 6,1992, p. 569–574.
53. Genta RM, Lew GW, Graham DY, “Changes in the gastric mucosa following
eradication of Helicobacter pylori,” Modern Pathology, 1993,vol. 6; no. 3, p.
281–289
54. Bernal C, Aguayo F, Villarroel C, et al., “Reprimo as a potential biomarker
for early detection in gastric cancer,” Clinical Cancer Research, vol. 14, no.
19, p. 6264–6269, 2008.
58
Universitas Sumatera Utara
55. Sapari NS, Loh M, Vaithilingam A, Soong R, “Clinical potential of DNA
methylation in gastric cancer: a metaanalysis,” PLoS One, vol. 7, no. 4,Article
ID e36275, 2012.
56. Carrasco G, Diaz J, Valbuena JR, et al., “Overexpression of p73 as a tissue
marker for high-risk gastritis,” Clinical Cancer Research, vol. 16, no. 12, pp.
3253–3259, 2010
57. Dixon MF, Genta RM, “Classification and grading of gastritis. The update
Sydney System. International workshop on the Histopathology of Gastrits,
Houston 1994” Am J Surg Pathol β0(10), 1161-1181, 1996
58. Elseweidy MM, Taha MM, younis NN et al, “ Gastritis induced by
helicobacter pylori infection in experimental rats” Dig Dis Sci 55, β7702777,2010
59. Rugge M, Pennelli G, Pilozzi E, Fassan M, et al. Gastritis: The histology
report. Digestive and liver Disease 2011;43:373-84
60. Yulida E, Oktaviynti IK, Rosida L. Gambaran derajat infiltrasi sel radang dan
infeksi Helicobacter pylori pada biopsi lambung pasien gastritis. Berkala
Kedokt. 2013;(1): 47-58
61. Szoke D. Genetic factors related to the histological and macroscopic lesions of
the stomach [Disertasi]. Budapest: Semmelweis University; 2009.pp.7-61
62. Aydin O, Egilmez R, Karabacak T, Kanik A. Interobserver variation in
Histophological assesment of Helicobacter pylori gastritis. World J
Gastroenterol 2003;9:2232-5
63. Rugge M, Genta RM. Staging and grading of chronic gastritis. Human
Pathol.2005;36:228-33
64. Rugge M, Correa P, Di Mario F, El-Omar E, Fiocca R, Geboes K, et al.
OLGA staging for gastritis: A tutorial. Dig liver Dis.2008;40(8):6508.doi:10.1016/j.dld.2008.02.030.
65. Garg B, Sandhu V, Sood N, Sood A, Malhotra V. Histopathological analysis
of chronic gastritis and correlation of pathological features with each other and
with endoscopic fi ndings. Pol J
59
Universitas Sumatera Utara
66. Guindy AE, Ghoraba H. A study of the concordance between endoscopic
gastritis and histological gastritis in nonulcer dyspeptic patients with and
without Helicobacter pylori infection.Tanta Med Sci J. 2007; 2(2): 67-82.
60
Universitas Sumatera Utara
1. El-Zimaity HMT. Recent advances in the histopathology of gastritis. Current
Diagnostic Pathology. 2007;13:340-8.
2. Djojoningrat D. Dispepsia Fungsional. Dalam: Sudoyo AW, editor. Buku ajar
Ilmu Penyakit Dalam. Jilid I edisi IV. Jakarta: BP FKUI; 2006: 354-6.
3. Rugge M, Genta RM. Staging and grading of chronic gastritis. Human
pathology. 2005;36:228-33.
4. Hirlan, Gastritis dalam Buku Ajar Ilmu Penyakit Dalam Edisi 5, Internal
Publishing : 2009 ; 509-512
5. Pratomo BW. Gastritis dan gastropati dalam buku ajar gastroenterologi. Edisi
I. Internal publishing. 2011:307-311.
6. Mayo clinic. Gastritis.2014 [diunduh 20 Maret 2015]. Tersedia dari :
http://www.mayoclinic.org
7. Rugge M, Pennelli G, Pilozzi E, Fassan M, Ingravallo G, Russo VM, et al.
Gastritis: the histology report. Digestive and Liver Disease. 2011; 43S:373–
84.
8. Adibi P. Gastritis. [Diunduh 19 Mei 2015]. Tersedia dari: http://med.mui.ac.ir
9. Szoke D. Genetic factors related to the histological and macroscopic lesions of
the stomach. [disertasi]. Budapest: Semmelweis University; 2009: 61-7.
10. Toljamo K. Gastric erosions – clinical significance and pathology. A longterm follow-up study. University of Oulu, Finland:Acta Univ Oul; 2012:80-1.
11. Zakaria Z. The role of interleukin-10 in Helicobacter pylori infection. Master
[Tesis]. Nottingham,UK: University of Nottingham; 2010: 55.
12. Fox JG, Megraud F. Helicobacter. In: Murray PR, editor. Manual of clinical
microbiology. 9th ed. Pensylvania: Elsevier Mosby; 2007 : 947-62.
13. Cesar ACG, Cury PM, Payao SLM. Comparison of histological and molecular
diagnosis of Helicobacter pylori in benign lesions and gastric adenocarcinoma.
Braz J Microbiol. 2005;36(1):261-6.
54
Universitas Sumatera Utara
14. Banerjee A, Mukhopadhyay AK, Paul S, Bhattacharyya A and Swarnakar S.
Unveiling the Intricacies of Helicobacter pylori-induced Gastric Inflammation:
T Helper cells and Matrix Metalloproteinases at a Crossroad. In: Mozsik G,
editor. Current Topics in Gastritis. Croatia: InTech Publishers; 2013: Chapter
7.
15. Hindawi Publishing Corporation BioMed Research International Volume
2014, Article ID 142980, 7 pages [diunduh 20 Februari 2016] .Tersedia dari:
http://dx.doi.org/10.1155/2014/142980
16. Rehnberg-Laiho L, Rautelin H, Koskela P, Sarna S, Pukkala E, Aromaa A, et
al. Decreasing prevalence of helicobacter antibodies in Finland, with reference
to the decreasing incidence of gastric cancer. Epidemiol Infect. 2001;126:4237.
17. Matsukura N, Yamada S, Kato S, Tomtitchong P, Tajiri T, Miki M, et al.
Genetic differences in interleukin-1 betapolymorphisms among four Asian
populations: an analysis of the Asian paradox between H. pylori infection and
gastric cancer incidence. J Exp Clin Cancer Res. 2003; 22: 55-47.
18. Adam B, et al. Cellular immune activation and clinical manifestation of
funcional dyspepsia. Z Gastroenterol 2008;26-46.
19. Elseweidy MM. Helicobacter pylori ifection and its relevant to chronic
gastritis. INTECH.2013.http://dx.doi.org/105772/46056
20. Conteduca vincenza, domenico sansonno, gianfranco lauletta, sabino russi,
giuseppe ingravallo and franco dammacco. H. pylori infection and gastric
cancer: State of the art. international journal of oncology. 2013.42: 5-18.
21. D W, Chey, C B, Wong. American college of gastroenterology guidline on the
management of H.pylori infetion. Am J Gastroenterol 2007;102:1808-1825
22. Lew E. Peptic ulcer disease. In: Greenberger NJ, editor. Current Diagnosis and
Treatment Gastroenterology, Hepatology, and Endoscopy. New York:
McGraw Hill; 2009:175-83.
23. Silva MIG, de Sousa FCF. Gastric ulcer etiology. In: Chai J, editor. Peptic
Ulcer Disease. Shanghai: Intech; 2011:p.3-28.
55
Universitas Sumatera Utara
24. Fornai M, Antonioli L, Colucci R, Tuccori M, Blandizzi C. Pathophysiology
of gastric ulcer development and healing: molecular mechanism and novel
therapeutic options. In: Chai J, editor. Peptic Ulcer Disease. Shanghai: Intech;
2011: 113-42.
25. Jones MK, Tomikawa M, Mohajer B, Tarnawski AS. Gastrointestinal mucosal
regeneration: role of growth factors. Frontiers in Bioscience. 1999b;4:303-9.
26. Brzozowski T, Konturek PC, Konturek SJ, Brzozowska I, Pawlik T. Role of
prostaglandins in gastroprotection and gastric adaptation. Journal of
physiology and pharmacology. 2005; 56:33-55.
27. Tarnawski AS, Chai J, Jones MK. Esophageal and Gastrointestinal
Microcirculation: Essential for Mucosal Protection, a Target for Injury, and a
Critical Component of Injury and Ulcer Healing. In: Ishii H, Suematsu M,
Tanishita K, editor. Organ microcirculation: a gateway to diagnostic and
therapeutic intervention. Tokyo: Springer; 2005:49-61.
28. Mueller A, Merrel DS, Grimm J, Falkow S. Profiling of microdissected gastric
epithelial cells reveals a cell-type specific response to Helicobacter pylori
infection. Gastroenterology. 2004;127:1446–62.
29. Markus S, Ruggiero P, Rappuoli R, Bagnoli F et al. Helicobacter pylori CagA:
from pathogenic mechanisms to its use as an anti-cancer vaccine. Frontier in
immunology. doi: 10.3389/fimmu.2013.00328
30. Akopyants NS, Clifton SW, Kersulyte D et al. Analyses of the cag
pathogenicity island of Helicobacter pylori. Mol Microbiol 1998; 28: 37–53
31. Kuipers EJ, Perez-Perez GI, Meuwissen SG, Blaser MJ. Helicobacter pylori
and atrophic gastritis: importance of the cagA status. J Natl Cancer Inst 1995;
87: 1777–80.
32. Crabtree JE, Taylor JD, Wyatt JI et al. Mucosal IgA recognition of
Helicobacter pylori 120 kDa protein, peptic ulceration, and gastric pathology.
Lancet 1991; 338: 332–5.
33. Blaser MJ, Perez-Perez GI, Kleanthous H et al. Infection with Helicobacter
pylori strains possessing cagA is associated with an increased risk of
developing adenocarcinoma of the stomach. Cancer Res 1995; 55: 2111–15.
56
Universitas Sumatera Utara
34. Parsonnet J, Friedman GD, Orentreich N, Vogelman H. Risk for gastric cancer
in people with CagA positive or CagA negative Helicobacter pylori infection.
Gut 1997; 40: 297–301.
35. Rugge M, Busatto G, Cassaro M et al. Patients younger than 40 years with
gastric carcinoma – Helicobacter pylori genotype and associated gastritis
phenotype. Cancer 1999; 85: 2506–11.
36. Shimoyama T, Fukuda S, Tanaka M, Mikami T, Munakata A, Crabtree JE.
CagA seropositivity associated with development of gastric cancer in a
Japanese population. J Clin Pathol 1998; 51: 225–8.
37. Nomura M, Lee J, Stemmermann GN, Nomura RY, Perez-Perez GI, Blaser
MJ. Helicobacter pylori CagA seropositivity and gastric carcinoma risk in a
Japanese American population. J Infect Dis 2002; 186: 1138–44.
38. Kikuchi S, Crabtree JE, Forman D, Kurosawa M. Association between
infections with CagA-positive or -negative strains of Helicobacter pylori and
risk for gastric cancer in young adults. Am J Gastroenterol 1999; 94: 3455–9.
39. Segal ED, Cha J, Lo J, Falkow S, Tompkins LS. Altered states: Involvement
of phosphorylated CagA in the induction of host cellular growth changes by
Helicobacter pylori. Proc Natl Acad Sci USA 1999; 96: 14 559–64.
40. Asahi M, Azuma T, Ito S et al. Helicobacter pylori CagA protein can be
tyrosine phosphorylated in gastric epithelial cells. J Exp Med 2000; 191: 593–
602.
41. Stein M, Rappuoli R, Covacci A. Tyrosine phosphorylation of the
Helicobacter pylori CagA antigen after cag-driven host cell translocation.
Proc Natl Acad Sci USA 2000; 97: 1263–8.
42. Odenbreit S, Puls J, Sedlmaier B, Gerland E, Fischer W, Haas R.Translocation
of Helicobacter pylori CagA into gastric epithelial cells by type IV secretion.
Science 2000; 287: 1497–500.
43. Backert S, Ziska E, Brinkmann V et al. Translocation of the Helicobacter
pylori CagA protein in gastric epithelial cells by a type IV secretion apparatus.
Cell Microbiol 2000; 2: 155–64.
57
Universitas Sumatera Utara
44. Selbach M, Moese S, Hauck CR, Meyer TF, Backert S. Src is the kinase of the
Helicobacter pylori CagA protein in vitro and in vivo. J Biol Chem 2002; 277:
677-758.
45. Stein M, Bagnoli F, Halenbeck R, Rappuoli R, Fantl WJ, Covacci A. cSrc/Lyn kinases activate Helicobacter pylori CagA through tyrosine
phosphorylation of the EPIYA motifs. Mol Microbiol 2002; 43: 971–80
46. orrea P, Haenszel W, Cuello C, Tannenbaum S, Archer M. A model for gastric
cancer epidemiology. Lancet 1975; 2: 58–60.
47. Yamazaki S, Yamakawa A, Ito Y et al. The CagA protein of Helicobacter
pylori is translocated into epithelial cells and binds to SHP- 2 in human gastric
mucosa. J Infect Dis 2003; 187: 334–7
48. R. Schindler, Gastritis,William Heinmann, London, UK, 1947.
49. Marshall BJ, Warren JR, “Unidentified curved bacilli in the stomach of
patients with gastritis and peptic ulceration,”The Lancet, vol. 1, no. 8390, pp.
1311–1315, 1984.
50. Jacobson BC, Crawford JM, Farraye FM, “GI tract endoscopic and tissue
processing techniques and normal histology in surgical pathology of the GI
tract,” in Liver, Biliary Tract and Pancreas, R. D. Odze and J. R. Goldblum,
Eds., Elsevier,2009.
51. Carneiro F, Fonseca E, Simoes S, “Epithelialdegeneration induced by
Helicobacter pylori,” Human Pathology, vol. 23, no. 11,1992, p. 1314–1315.
52. Leung KM, Hui Pk, Chan W, Thomas T, “Helicobacter pylori-related gastritis
and gastric ulcer: a continuum of progressive epithelial degeneration,”
American Journal of Clinical Pathology, vol. 98, no. 6,1992, p. 569–574.
53. Genta RM, Lew GW, Graham DY, “Changes in the gastric mucosa following
eradication of Helicobacter pylori,” Modern Pathology, 1993,vol. 6; no. 3, p.
281–289
54. Bernal C, Aguayo F, Villarroel C, et al., “Reprimo as a potential biomarker
for early detection in gastric cancer,” Clinical Cancer Research, vol. 14, no.
19, p. 6264–6269, 2008.
58
Universitas Sumatera Utara
55. Sapari NS, Loh M, Vaithilingam A, Soong R, “Clinical potential of DNA
methylation in gastric cancer: a metaanalysis,” PLoS One, vol. 7, no. 4,Article
ID e36275, 2012.
56. Carrasco G, Diaz J, Valbuena JR, et al., “Overexpression of p73 as a tissue
marker for high-risk gastritis,” Clinical Cancer Research, vol. 16, no. 12, pp.
3253–3259, 2010
57. Dixon MF, Genta RM, “Classification and grading of gastritis. The update
Sydney System. International workshop on the Histopathology of Gastrits,
Houston 1994” Am J Surg Pathol β0(10), 1161-1181, 1996
58. Elseweidy MM, Taha MM, younis NN et al, “ Gastritis induced by
helicobacter pylori infection in experimental rats” Dig Dis Sci 55, β7702777,2010
59. Rugge M, Pennelli G, Pilozzi E, Fassan M, et al. Gastritis: The histology
report. Digestive and liver Disease 2011;43:373-84
60. Yulida E, Oktaviynti IK, Rosida L. Gambaran derajat infiltrasi sel radang dan
infeksi Helicobacter pylori pada biopsi lambung pasien gastritis. Berkala
Kedokt. 2013;(1): 47-58
61. Szoke D. Genetic factors related to the histological and macroscopic lesions of
the stomach [Disertasi]. Budapest: Semmelweis University; 2009.pp.7-61
62. Aydin O, Egilmez R, Karabacak T, Kanik A. Interobserver variation in
Histophological assesment of Helicobacter pylori gastritis. World J
Gastroenterol 2003;9:2232-5
63. Rugge M, Genta RM. Staging and grading of chronic gastritis. Human
Pathol.2005;36:228-33
64. Rugge M, Correa P, Di Mario F, El-Omar E, Fiocca R, Geboes K, et al.
OLGA staging for gastritis: A tutorial. Dig liver Dis.2008;40(8):6508.doi:10.1016/j.dld.2008.02.030.
65. Garg B, Sandhu V, Sood N, Sood A, Malhotra V. Histopathological analysis
of chronic gastritis and correlation of pathological features with each other and
with endoscopic fi ndings. Pol J
59
Universitas Sumatera Utara
66. Guindy AE, Ghoraba H. A study of the concordance between endoscopic
gastritis and histological gastritis in nonulcer dyspeptic patients with and
without Helicobacter pylori infection.Tanta Med Sci J. 2007; 2(2): 67-82.
60
Universitas Sumatera Utara